Check-Cap (NASDAQ:CHEK) Now Covered by StockNews.com

StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK) in a report released on Monday morning. The brokerage issued a sell rating on the medical research company’s stock.

Check-Cap Trading Up 3.7 %

Shares of Check-Cap stock opened at $2.26 on Monday. The company’s fifty day simple moving average is $2.24 and its two-hundred day simple moving average is $2.62. The company has a market cap of $13.22 million, a P/E ratio of -0.77 and a beta of 0.28. Check-Cap has a 12-month low of $1.27 and a 12-month high of $4.63.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Virtu Financial LLC grew its position in shares of Check-Cap by 363.4% in the 2nd quarter. Virtu Financial LLC now owns 224,696 shares of the medical research company’s stock worth $69,000 after buying an additional 176,207 shares during the period. Sabby Management LLC purchased a new stake in shares of Check-Cap in the 1st quarter worth about $91,000. Citadel Advisors LLC grew its position in shares of Check-Cap by 51.2% in the 3rd quarter. Citadel Advisors LLC now owns 141,319 shares of the medical research company’s stock worth $41,000 after buying an additional 47,868 shares during the period. Susquehanna International Group LLP purchased a new stake in shares of Check-Cap in the 1st quarter worth about $57,000. Finally, Nantahala Capital Management LLC purchased a new stake in shares of Check-Cap in the 4th quarter worth about $69,000. 1.07% of the stock is owned by hedge funds and other institutional investors.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.